Global Health Risk Framework

Since the 2014 Ebola outbreak many public- and private-sector leaders have seen a need for improved management of global public health emergencies. The effects of the Ebola epidemic go well beyond the three hardest-hit countries and beyond the health sector. Education, child protection, commerce, transportation, and human rights have all suffered. The consequences and lethality of Ebola have increased interest in coordinated global response to infectious threats, many of which could disrupt global health and commerce far more than the recent outbreak. In order to explore the potential for improving international management and response to outbreaks the National Academy of Medicine agreed to manage an international, independent, evidence-based, authoritative, multistakeholder expert commission. As part of this effort, the Institute of Medicine convened four workshops in summer of 2015 to inform the commission report. The presentations and discussions from the Workshop on Research and Development of Medical Products are summarized in this report. Table of ContentsFront Matter1 Introduction2 Models and Incentives for Engagement3 Discovery Research4 Development5 Convergence of Regulatory Expectations, Review, and Approval6 Manufacturing, Stockpiling, and Distribution7 Critical Considerations for Facilitating Medical Product Research and Development8 Crosscutting Themes and Closing RemarksAppendix A: ReferencesAppendix B: Workshop Statement of TaskAppendix C: Workshop AgendaAppendix D: Workshop Speaker Biographies